Edition:
United States

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

23.10USD
3:59pm EST
Change (% chg)

$-0.46 (-1.95%)
Prev Close
$23.56
Open
$23.50
Day's High
$23.88
Day's Low
$23.00
Volume
85,128
Avg. Vol
75,758
52-wk High
$29.29
52-wk Low
$11.05

Chart for

About

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company. The Company is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on... (more)

Overall

Beta: --
Market Cap(Mil.): $759.71
Shares Outstanding(Mil.): 32.25
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 189.80 16.52
EPS (TTM): -- -- --
ROI: -- -0.65 36.19
ROE: -- -3.21 17.38

BRIEF-Jounce Therapeutics reports Q3 loss $0.13/shr

* Jounce Therapeutics reports third quarter 2017 financial results

Nov 13 2017

BRIEF-Partner Fund Management L.P reports 5.4 pct passive stake in Jounce Therapeutics

* Partner Fund Management L.P reports 5.4 percent passive stake in Jounce Therapeutics Inc as of Sept 19, 2017 - SEC Filing Source text: (http://bit.ly/2ydfJp1) Further company coverage:

Sep 29 2017

Competitors

Earnings vs. Estimates